Form 4: Elanco Animal Health Executive Sells Shares
Statement of Changes in Beneficial Ownership
Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., reported a transaction involving deferred stock units.
Summary
- Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc., engaged in a transaction on June 26, 2026.
- The transaction involved deferred stock units, where each unit represents the right to receive one share of Company common stock or its cash equivalent.
- The transaction code indicates an acquisition (A) with a price of $8.0187 per unit.
- Following the transaction, Mr. VanHimbergen beneficially owns 108.8506 shares of common stock, held directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine disclosure of an executive's transaction with deferred stock units, not indicative of company performance or strategic shifts.
Future Outlook
The filing does not contain any forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal company performance, but rather individual executive actions regarding their holdings.
Key Dates
| Date | Description |
|---|---|
| 06/26/2026 | Earliest transaction date and transaction date for deferred stock units. |
| 06/30/2026 | Signature date of the filing. |
Keywords
Elanco Animal Health, SEC Form 4, Insider Trading, Stock Transaction, Deferred Stock Units, EVP and CFO, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.